BETA GAL MRNA: beta-galactosidase encoding mRNA 100g

mRNA Vaccines offer several advantages over traditional DNA and viral-based approaches: Express the desired antigen and act as an adjuvant. Prevent risk of genomic integration and no inactivated viruses or pathogens are needed. No need of nuclear uptake - protein expression directly in cytoplasm Perfect for transfecting slowing or non-dividing cells such as Antigen Presenting cells (DCs) Faster protein expression than DNA transfection Protein expression in a total promoter-independent manner Transient transfection: mRNA based expression of proteins sustains for a limited timeWe offer modified OVA mRNA and unmodified OVA mRNAs: Exogenous unmodified mRNAs activate the innate immune system and production of cytokines in order to influence induced immune response but is rapidely degraded. Modified mRNAs reduce this effect but last longer in the organism due to the stabilization and protection.They are capped (Cap 0) and polyadenylated mRNA optimized for mammalian systems with modified nucleotids to reduce immune stimulation.

Size: 100µg
Storage temperature: -80C
Transport temperature: Dry ice

Delivery time: 2-14days

Supplier: OZ Biosciences SAS